| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.07 | 0.2 |